Short Interest in Medirom Healthcare Technologies Inc. (NASDAQ:MRM) Drops By 59.8%

Medirom Healthcare Technologies Inc. (NASDAQ:MRMGet Free Report) saw a significant drop in short interest in the month of June. As of June 15th, there was short interest totaling 136,211 shares, a drop of 59.8% from the May 31st total of 338,625 shares. Approximately 0.8% of the shares of the stock are short sold. Based on an average daily trading volume, of 68,176 shares, the short-interest ratio is currently 2.0 days.

Analysts Set New Price Targets

Separately, Weiss Ratings cut Medirom Healthcare Technologies from a “sell (d+)” rating to a “sell (d)” rating in a research report on Thursday, May 28th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has an average rating of “Sell”.

View Our Latest Stock Analysis on Medirom Healthcare Technologies

Medirom Healthcare Technologies Trading Up 3.0%

Shares of Medirom Healthcare Technologies stock opened at $1.03 on Wednesday. Medirom Healthcare Technologies has a 1 year low of $0.90 and a 1 year high of $4.45. The company has a 50 day simple moving average of $1.12 and a two-hundred day simple moving average of $1.38.

About Medirom Healthcare Technologies

(Get Free Report)

MEDIROM Healthcare Technologies Inc provides holistic healthcare services in Japan. It operates in two segments, Relaxation Salon and Digital Preventative Healthcare. The Relaxation Salon segment owns and franchises relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology.

Featured Articles

Receive News & Ratings for Medirom Healthcare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medirom Healthcare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.